Literature DB >> 17938614

Diabetes and cardiovascular disease: explaining the relationship.

Zubin Punthakee1, Geoff H Werstuck, Hertzel C Gerstein.   

Abstract

Diabetes is a risk factor for cardiovascular disease. However, even elevated glucose levels below the diabetic range increase cardiovascular risk. There are several possible explanations for this relationship. First, glucose and its metabolites have direct toxic effects on vascular endothelium. Second, abnormal glucose is evidence of absolute or relative insulin deficiency, which can predispose patients to cardiovascular disease via endothelial dysfunction, lipid abnormalities, and inflammation. Third, antecedent factors, such as toxins, abnormal energy storage, and hypertension, may contribute to the development of both diabetes and cardiovascular disease. Whether glucose lowering can reduce the risk of cardiovascular disease is currently being studied in a number of large trials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17938614

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  9 in total

1.  Dysglycaemia, dyslipidaemia and hypertension: risk factors primarily focused on the disease or risk estimates primarily focused on the patient?

Authors:  H C Gerstein
Journal:  Diabetologia       Date:  2010-11-20       Impact factor: 10.122

2.  Diabetes and cardiovascular disease: the role of glycemic control.

Authors:  Alice Y Y Cheng; Lawrence A Leiter
Journal:  Curr Diab Rep       Date:  2009-02       Impact factor: 4.810

3.  Prenatal arsenic exposure alters gene expression in the adult liver to a proinflammatory state contributing to accelerated atherosclerosis.

Authors:  J Christopher States; Amar V Singh; Thomas B Knudsen; Eric C Rouchka; Ntube O Ngalame; Gavin E Arteel; Yulan Piao; Minoru S H Ko
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

4.  A potent risk model for predicting new-onset acute coronary syndrome in patients with type 2 diabetes mellitus in Northwest China.

Authors:  Jun Lyu; Zhiying Li; Huiyi Wei; Dandan Liu; Xiaoxian Chi; Da-Wei Gong; Qingbin Zhao
Journal:  Acta Diabetol       Date:  2020-02-01       Impact factor: 4.280

5.  Pilot Study on the Effect of Orally Administered Bisphenol A on Glucose and Insulin Response in Nonobese Adults.

Authors:  Todd Alan Hagobian; Alyssa Bird; Sean Stanelle; Dana Williams; Andrew Schaffner; Suzanne Phelan
Journal:  J Endocr Soc       Date:  2019-02-08

6.  Improved Metabolic Control in Diabetes, HSP60, and Proinflammatory Mediators.

Authors:  Claudio Blasi; Eunjung Kim; Anne A Knowlton
Journal:  Autoimmune Dis       Date:  2012-08-12

7.  Cardiovascular disease, neuropathy, and retinopathy.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2009-06       Impact factor: 19.112

8.  Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Jinlida Granules on Metabolic Syndrome in Patients With Abnormal Glucose Metabolism.

Authors:  Lili Hou; Shuolong Han; Liping Chang; Huailin Gao; Yiru Zhao; Shenghui Zhao; Xuedong An; Guangyao Song; Chunli Piao; Fengmei Lian; Tong Xiao-Lin; Zhenhua Jia
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-25       Impact factor: 5.555

9.  Effects of Antihypertensive Drugs on Thyroid Function in Type 2 Diabetes Patients With Euthyroidism.

Authors:  Lijuan Yang; Xiuqin Sun; Yi Zhao; Hong Tao
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.